143 results on '"Di Carli, Marcelo F"'
Search Results
2. Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis
3. Prognostic value of myocardial flow reserve vs corrected myocardial flow reserve in patients without obstructive coronary artery disease
4. Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure
5. Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW
6. Cardiac Amyloid Quantification Using 124I-Evuzamitide (124I-P5+14) Versus 18F-Florbetapir: A Pilot PET/CT Study
7. Coronary artery disease grading by cardiac CT for predicting outcome in patients with stable angina
8. Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification
9. Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial
10. Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer
11. Multimodality imaging to distinguish between benign and malignant cardiac masses
12. Impact of coronary artery calcium testing on patient management
13. Plasma Proteomics of COVID-19–Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics
14. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis
15. Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy
16. Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease
17. Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation
18. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders
19. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT
20. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria
21. Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study
22. Use of cardiac CT amidst the COVID-19 pandemic and beyond: North American perspective
23. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
24. Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry
25. PET Perfusion and Flow Assessment: Tomorrows’ Technology Today
26. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction
27. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis
28. Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis
29. Fully Automated Quantitation of 99mTc-PYP SPECT/CT Images Using Artificial Intelligence-Based Segmentation of Low-Dose CTAC
30. The Updated REgistry of Fast Myocardial Perfusion Imaging With NExt Generation SPECT
31. Defining the Optimal Imaging Technique With 18F-Flutemetamol PET To Diagnose Transthyretin Cardiac Amyloidosis
32. Prognostic Value of Myocardial Flow Reserve in Coronary Artery Bypass Patients
33. Enhanced Risk Prediction for Cardiac PET/CT Using Cardiac Chamber Volumes and Myocardial Mass Derived From CT Attenuation Maps Using Deep Learning
34. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review
35. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction
36. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients
37. Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction
38. Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO
39. Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry
40. Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging
41. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?
42. Utility of multimodality imaging in myopericarditis with aortitis
43. Utility of multimodality imaging in diagnosis and follow-up of aortitis
44. Utility of multimodality imaging in suspected prosthetic valve endocarditis
45. Total coronary atherosclerotic plaque burden assessment by CT angiography for detecting obstructive coronary artery disease associated with myocardial perfusion abnormalities
46. Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease
47. 3D printing based on cardiac CT assists anatomic visualization prior to transcatheter aortic valve replacement
48. Proceedings of the Cardiac PET Summit, 12 May 2014, Baltimore, MD: 3: Quantitation of myocardial blood flow
49. Abnormal Exercise Response in Long-Term Survivors of Hodgkin Lymphoma Treated With Thoracic Irradiation: Evidence of Cardiac Autonomic Dysfunction and Impact on Outcomes
50. Cardiac PET Perfusion: Prognosis, Risk Stratification, and Clinical Management
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.